Marilena Vrana/LinkedIn
Jan 7, 2026, 13:40
Marilena Vrana Invites You to IPPC2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”Happy New Year!
There’s a lot to look forward to in 2026, but one thing I’m especially excited about is the official opening of IPPC2026 registration.
Save the date: registration opens 26 January
Bookmark.
The website will soon feature updated information about the 28-29 April programme in Milan, Italy.
From my behind-the-scenes vantage point, I can confidently say there’s a lot to look forward to, with programming focused on data, science, innovation, and more, bringing together insights shaping the future of plasma protein therapeutics.
I look forward to seeing you in Milan at IPPC2026!”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1